Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BSGMNASDAQ:CVRXNYSE:ELMDNASDAQ:MODD On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBSGMBioSig Technologies$6.39-7.5%$2.95$0.23▼$8.80$174.42M1.66316,504 shs817,638 shsCVRXCVRx$5.86-1.2%$6.57$4.30▼$18.55$152.79M1.3326,026 shs282,241 shsELMDElectromed$20.07+0.3%$21.68$13.74▼$35.56$168.31M0.473,341 shs55,783 shsMODDModular Medical$0.77-3.4%$0.91$0.68▼$2.65$41.77M0.22211,131 shs56,153 shsThe 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBSGMBioSig Technologies0.00%-12.82%+150.59%+941.56%+1,259.57%CVRXCVRx0.00%-10.67%-5.33%-48.78%-42.72%ELMDElectromed0.00%-4.20%+2.66%-18.48%+35.88%MODDModular Medical0.00%-8.77%-22.38%-14.35%-56.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBSGMBioSig Technologies2.4986 of 5 stars3.50.00.00.04.00.80.6CVRXCVRx3.039 of 5 stars3.42.00.00.02.84.20.6ELMDElectromed1.4331 of 5 stars2.05.00.00.00.61.70.6MODDModular Medical1.781 of 5 stars0.04.00.00.03.83.30.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBSGMBioSig Technologies 3.00Buy$10.0056.49% UpsideCVRXCVRx 2.71Moderate Buy$14.50147.44% UpsideELMDElectromed 4.00Strong Buy$38.0089.34% UpsideMODDModular Medical 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest MODD, CVRX, BSGM, and ELMD Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/6/2025BSGMBioSig TechnologiesAscendiant Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$2.50 ➝ $10.005/15/2025ELMDElectromedB. RileySubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy5/9/2025CVRXCVRxPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$20.00 ➝ $12.005/9/2025CVRXCVRxJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Underweight$15.00 ➝ $7.004/21/2025BSGMBioSig TechnologiesAscendiant Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$2.75 ➝ $2.504/8/2025CVRXCVRxLake Street CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$19.00 ➝ $14.004/8/2025CVRXCVRxCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$23.00 ➝ $18.00(Data available from 6/15/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBSGMBioSig Technologies$26K6,708.27N/AN/A($0.33) per share-19.36CVRXCVRx$52.87M2.89N/AN/A$2.73 per share2.15ELMDElectromed$61.44M2.74$0.49 per share41.36$5.10 per share3.94MODDModular MedicalN/AN/AN/AN/A$0.25 per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBSGMBioSig Technologies-$29.04MN/A0.00N/AN/A-44,832.50%N/A-776.49%8/13/2025 (Estimated)CVRXCVRx-$59.97M-$2.18N/AN/AN/A-116.91%-93.06%-51.78%8/4/2025 (Estimated)ELMDElectromed$5.15M$0.7926.76∞N/A11.34%15.71%13.37%N/AMODDModular Medical-$17.47M-$0.53N/A∞N/AN/A-197.97%-162.31%6/19/2025 (Estimated)Latest MODD, CVRX, BSGM, and ELMD EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/19/2025Q1 2025BSGMBioSig Technologies-$0.05-$0.14-$0.09-$0.14N/AN/A5/8/2025Q1 2025CVRXCVRx-$0.56-$0.53+$0.03-$0.53$14.68 million$12.35 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBSGMBioSig TechnologiesN/AN/AN/AN/AN/ACVRXCVRxN/AN/AN/AN/AN/AELMDElectromedN/AN/AN/AN/AN/AMODDModular MedicalN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBSGMBioSig TechnologiesN/A0.500.50CVRXCVRx0.6912.0610.23ELMDElectromedN/A5.104.74MODDModular MedicalN/A5.305.30Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBSGMBioSig Technologies7.16%CVRXCVRx75.27%ELMDElectromed40.82%MODDModular Medical27.47%Insider OwnershipCompanyInsider OwnershipBSGMBioSig Technologies17.03%CVRXCVRx13.90%ELMDElectromed14.00%MODDModular Medical20.46%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBSGMBioSig Technologies5027.30 million14.30 millionNo DataCVRXCVRx16026.07 million21.12 millionOptionableELMDElectromed1608.39 million7.36 millionOptionableMODDModular Medical2054.25 million32.35 millionNot OptionableMODD, CVRX, BSGM, and ELMD HeadlinesRecent News About These CompaniesModular Medical adds insulin delivery tech veteran to boardMay 29, 2025 | drugdeliverybusiness.comModular Medical, Inc.: Modular Medical Appoints Industry Veteran Jeff Goldberg to Board of DirectorsMay 29, 2025 | finanznachrichten.deModular Medical Appoints Industry Veteran Jeff Goldberg to Board of DirectorsMay 28, 2025 | accessnewswire.comRegistration Is Now Open For Tribe Public's CEO Presentation and Q&A Webinar Event Titled "Making Diabetes Management Simpler: The New Era of Insulin Therapy" Featuring Modular Medical CEO - Wednesday, May 28, 2025May 27, 2025 | accessnewswire.comModular Medical to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025May 22, 2025 | accessnewswire.comModular Medical files to sell 20.4M shares of common stock for holdersApril 26, 2025 | markets.businessinsider.comManchester Management Co Llc Acquires 156,250 Shares of Modular Medical, Inc. (NASDAQ:MODD) StockMarch 25, 2025 | insidertrades.comModular Medical announces $12M private placementMarch 21, 2025 | drugdeliverybusiness.comModular Medical, Inc.: Modular Medical Announces $12 Million Private PlacementMarch 20, 2025 | finanznachrichten.deModular Medical Announces $12 Million Private PlacementMarch 20, 2025 | accessnewswire.comModular Medical takes step forward in CE mark process for insulin pump techFebruary 3, 2025 | drugdeliverybusiness.comModular Medical Announces BSI Group as Trusted Body for CE Mark ClearanceJanuary 30, 2025 | accessnewswire.comModular Medical, Inc.: Modular Medical Announces Licensing and Partnership Agreement With Nudge BGDecember 19, 2024 | finanznachrichten.deModular Medical Announces Licensing and Partnership Agreement With Nudge BGDecember 19, 2024 | accesswire.comManchester Management Co Llc Buys 21,000 Shares of Modular Medical, Inc. (NASDAQ:MODD) StockDecember 5, 2024 | insidertrades.comModular Medical brings in $8.2MDecember 3, 2024 | drugdeliverybusiness.comModular Medical Announces Conference Call to Provide Business UpdateDecember 3, 2024 | finance.yahoo.comFavourable Signals For Modular Medical: Numerous Insiders Acquired StockDecember 2, 2024 | uk.finance.yahoo.comInsider Buying: Modular Medical, Inc. (NASDAQ:MODD) Director Buys 100,000 Shares of StockNovember 30, 2024 | insidertrades.comManchester Management Co Llc Purchases 166,666 Shares of Modular Medical, Inc. (NASDAQ:MODD) StockNovember 26, 2024 | insidertrades.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeMODD, CVRX, BSGM, and ELMD Company DescriptionsBioSig Technologies NASDAQ:BSGM$6.39 -0.52 (-7.53%) Closing price 06/13/2025 04:00 PM EasternExtended Trading$6.50 +0.11 (+1.72%) As of 06/13/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.BioSig Technologies, Inc., together with its subsidiaries, a medical device company, engages in development and commercialization of advanced digital signal processing technology platform for the treatment of cardiovascular arrhythmias in the United States. It offers PURE EP system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. The company has a research agreement with Mayo Foundation to develop an AI- and machine learning-powered software for PURE EP system. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.CVRx NASDAQ:CVRX$5.86 -0.07 (-1.18%) Closing price 06/13/2025 04:00 PM EasternExtended Trading$6.10 +0.24 (+4.03%) As of 06/13/2025 05:24 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. The company offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure with reduced ejection fraction or systolic heart failure. It sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, and internationally. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.Electromed NYSE:ELMD$20.07 +0.06 (+0.30%) Closing price 06/13/2025 04:00 PM EasternExtended Trading$20.08 +0.01 (+0.05%) As of 06/13/2025 07:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products to hospitals, home health care centers, pulmonary rehabilitation centers, cystic fibrosis centers, neuromuscular clinics, and other clinics through distributors. It markets its products to physicians, health care providers, and directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.Modular Medical NASDAQ:MODD$0.77 -0.03 (-3.39%) Closing price 06/13/2025 04:00 PM EasternExtended Trading$0.77 0.00 (0.00%) As of 06/13/2025 06:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Modular Medical, Inc. operates as a medical device company. It focuses on the design, development, and commercialization of insulin pumps. It offers MODD1, a two-part patch pump for type-1 and type-2 diabetes. The company is headquartered in San Diego, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 06/09 - 06/13 Alphabet Enters a Bull Market: Is It Time to Buy? Ouster Soars 27% as DoD Grants First 3D LiDAR Approval for Drones RH Stock Rockets on Surprise Profit and Tariff Shift Super Micro Computer Stock: 2 Levels Smart Money Is Watching Intel's Price Spikes: Noise, or the First Notes of a Turnaround? IBM Up 10 Days in a Row: What’s Driving the Winning Streak? SoFi Stock’s Next Test: Can It Justify Its Premium Valuation? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
